Identification of Novel Genetic Risk Factors for Cerebral Amyloid Angiopathy
We expect this study will provide further insights into the genetic architecture underlying risk for CAA, both in the context of significant AD pathology, and without. Characterization of genetic variants and their functional outcomes may lead to new avenues of research aimed at identifying biomarkers and therapies to treat CAA, a common co-pathology in those with and without AD.
Authors
- Dennis W. Dickson (ORCID: https://orcid.org/0000-0001-7189-7917)
- Joseph S. Reddy (ORCID: https://orcid.org/0000-0002-1783-4453)
- Jonathan Graff‐Radford
- Michael DeTure (ORCID: https://orcid.org/0000-0002-4363-1262)
- Mariet Allen (ORCID: https://orcid.org/0000-0002-2685-427X)
- Minerva M. Carrasquillo
- Thuy T. Nguyen
- Merve Atik
- Frederick Q Tutor‐New
- Katie D. Sotelo
- Nilüfer Ertekin‐Taner
- Kejal Kantarci
- Neill R. Graff‐Radford
Institutions
- Mayo Clinic (US)
- Jacksonville College (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70862_110058
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00